144
Views
6
CrossRef citations to date
0
Altmetric
Original Article

Chemotherapeutic potential of novel non-toxic nucleoside analogues on EAC ascitic tumour cells

, , , , &
Pages 57-67 | Received 21 Jun 2018, Accepted 20 Nov 2018, Published online: 09 Jan 2019

References

  • Cheson BD. New antimetabolites in the treatment of human malignancies. Semin Oncol. 1992;19:695–706.
  • Norbeck DW, Spanton S, Broder S, Mitsuya H. (±)-Dioxolane-T ((±)-1-[(2β,4β)-2-(hydroxymethyl)-4-dioxolanyl]thymine). Tetrahedron Lett. 1989;30:6263–6266.
  • Ewald B, Sampath D, Plunkett W. Nucleoside analogs: molecular mechanisms signaling cell death. Oncogene. 2008;27:6522–6537.
  • Chu CK, Antiviral nucleosides: chiral synthesis and chemotherapy. New York: Elsevier; 2003.
  • Tripathi S, Maity JK, Achari B, Mandal SB. Bicyclic nucleoside analogues from d-glucose: synthesis of chiral as well as racemic 1,4-dioxepane ring-fused derivatives. Carbohydr Res. 2005;340:1081–1087.
  • Chen L, Watkins JF. Evidence against the presence of H2 histocompatibility antigens in Ehrlich ascites tumour cells. Nature. 1970;225:734–735.
  • Jaganathan SK, Mondhe D, Wani ZA, Pal HC, Mandal M. Effect of honey and eugenol on Ehrlich ascites and solid carcinoma. J Biomed Biotechnol. 2010;2010:989163.
  • Patt HM, Straube RL. Measurement and nature of ascites tumor growth. Ann N Y Acad Sci. 1956;63:728–737.
  • Bhattacharjya A, Chattopadhyay P, McPhail AT. Intramolecular 1,3-dipolar cycloaddition of a nitrone derived from 3-O-allyl-D-(+)-glucose: an expedient synthesis of a chiral oxepane derivative. J Chem Soc, Chem Commun. 1990;0:1508–1509.
  • Roy BG, Roy A, Achari B, Mandal SB. A simple one-pot entry to cyclic ethers of varied ring sizes from diols via phosphonium ion induced iodination and base catalyzed Williamson etherification. Tetrahedron Lett. 2006;47:7783–7787.
  • Majumdar S, Bhattacharjya A. Thiourea: a novel cleaving agent for 1,3-dioxolanes. J Org Chem. 1999;64:5682–5685.
  • Niedballa U, Vorbrueggen H. A general synthesis of N-glycosides. I. Synthesis of pyrimidine nucleosides. J Org Chem. 1974;39:3654–3660.
  • Bhattacharyya A, Choudhuri T, Pal S. Apoptogenic effects of black tea on Ehrlich’s ascites carcinoma cell. Carcinogenesis. 2003;24:75–80.
  • Chattopadhyay S, Das T, Sa G, Ray PK. Protein A-activated macrophages induce apoptosis in Ehrlich’s ascites carcinoma through a nitric oxide-dependent pathway. Apoptosis. 2002;7:49–57.
  • Alstead S. Observations on Sahli’s haemoglobinometer. Postgrad Med J. 1940;16:278–286.
  • Saraswati S, Agrawal SS, Alhaider AA. Ursolic acid inhibits tumor angiogenesis and induces apoptosis through mitochondrial-dependent pathway in Ehrlich ascites carcinoma tumor. Chem Biol Interact. 2013;206:153–165.
  • Andrade VA, Almeida AC, Souza DS, et al. Antimicrobial activity and acute and chronic toxicity of the essential oil of Lippia origanoides. Pesq Vet Bras. 2014;34:1153–1161.
  • Pal D, Sur S, Mandal S, Das S, Panda CK. Regular black tea habit could reduce tobacco associated ROS generation and DNA damage in oral mucosa of normal population. Food Chem Toxicol. 2012;50:2996–3003.
  • Manna S, Banerjee S, Mukherjee S, Das S, Panda CK. Epigallocatechin gallate induced apoptosis in sarcoma180 cells in vivo: mediated by p53 pathway and inhibition in U1B, U4-U6 UsnRNAs expression. Apoptosis. 2006;11:2267–2276.
  • Subramoniam A, Shylesh B, Nair S. Induction of cell-specific apoptosis and protection from Dalton’s lymphoma challenge in mice by an active fraction from Emilia sonchifolia. Indian J Pharmacol. 2005;37:232.
  • Saha P, Das S. Regulation of hazardous exposure by protective exposure: modulation of phase II detoxification and lipid peroxidation by Camellia sinensis and Swertia chirata. Teratog Carcinog Mutagen. 2003;23:313–322.
  • Lowry OH, Rosebrough NJ, Farr AL, et al. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265–275.
  • Xie C, Yi J, Lu J, Nie M, Huang M, Rong J, et al. N-acetylcysteine reduces ROS-mediated oxidative DNA damage and PI3K/Akt pathway activation induced by Helicobacter pylori infection. Oxid Med Cell Longev. 2018;2018:1874985.
  • Galmarini CM, Mackey JR, Dumontet C. Nucleoside analogues: mechanisms of drug resistance and reversal strategies. Leukemia. 2001;15:875–890.
  • Radley JM, Scurfield G. Effects of 5-fluorouracil on mouse bone marrow. Br J Haematol. 1979;43:341–351.
  • Chandrashekar NS, Hiremath SRR. Transdermal delivery of 5-fluorouracil for induced Ehrlich ascites carcinoma tumor in BALB/c mice and pharmacokinetic study. Recent Pat Anticanc Drug Discov. 2007;2:235–239.
  • Preston RJ, Dean BJ, Galloway S, et al. Mammalian in vivo cytogenetic assays. Analysis of chromosome aberrations in bone marrow cells. Mutat Res. 1987;189:157–165.
  • Longley DB, Harkin DP, Johnston PG. 5-Fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer. 2003;3:330–338.
  • Masuda M, Suzui M, Weinstein IB. Effects of epigallocatechin-3-gallate on growth, epidermal growth factor receptor signaling pathways, gene expression, and chemosensitivity in human head and neck squamous cell carcinoma cell lines. Clin Cancer Res. 2001;7:4220–4229.
  • Fawthrop DJ, Boobis AR, Davies DS. Mechanisms of cell death. Arch Toxicol. 1991;65:437–444.
  • Bracht K, Nicholls AM, Liu Y, Bodmer WF. 5-Fluorouracil response in a large panel of colorectal cancer cell lines is associated with mismatch repair deficiency. Br J Cancer. 2010;103:340–346.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.